Tetrahydrocannabinol

Delta(9)-tetrahydrocannabinol is a diterpenoid that is 6a,7,8,10a-tetrahydro-6H-benzo[c]chromene substituted at position 1 by a hydroxy group, positions 6, 6 and 9 by methyl groups and at position 3 by a pentyl group. The principal psychoactive constituent of the cannabis plant, it is used for treatment of anorexia associated with AIDS as well as nausea and vomiting associated with cancer chemotherapy. Among its listed roles, it functions as a metabolite, a non-narcotic analgesic, a hallucinogen, a cannabinoid receptor agonist and an epitope. It is a diterpenoid, a benzochromene, a polyketide and a phytocannabinoid. It is grouped under the following drug class(es): Cannabinoids. Its therapeutic use is listed as analgesics. The directory classifies it as a commercial API with a natural source/manufacturing origin. Other names for this substance include delta9-Tetrahydrocannabinol, Syndros, Marinol and Dronabinol. It is listed as a controlled drug substance (Schedule I). Its PubChem CID is 16078.